What Are Peptides Used For?

Definition of peptides

Peptides are required for several metabolic reactions and have an important function in basic physiological functions. A condensation reaction forms peptides, which are short strings of 2–50 amino acids that are joined together by covalent bonds. The fundamental unit of proteins, amino acids form peptide chains by a series of sequential covalent interactions with other amino acids. The sequence of amino acid residues is the naming factor for peptides. When 10–20 amino acids are present in a peptide chain, the main structure of the amino acids can increase to produce an oligopeptide. In living organisms, peptide chains are formed by joining the amino-terminal of one amino acid with each additional amino acid. A polypeptide is an unbranched chain of amino acids with more than 20 amino acids.

Many different types of molecules with distinct physical, chemical, and pharmacological characteristics fall under the umbrella term "peptide." These compounds range in molecular weight from extremely small to very large. Proteins can be categorized according to their molecular structure. The simplest proteins, such as albumins, globulins, prolamines, and glutalins, are formed from just two amino acid molecules. On the other hand, more complex proteins can be classified as conjugated proteins, which contain additional groupings such as carbohydrates in mucoproteins, chlorophyll in chloroplast proteins, phosphorus in casein, nucleic acid in nucleoproteins, and lipids in cytoplasmic lipoproteins. Several cyclic peptide antibiotics (e.g., gramicidin, bacitracin, and polymyxin) and peptide hormones (e.g., oxytocin and vasopressin) secreted by the posterior pituitary gland and the ubiquitous glutathione are examples of substances with a relatively low molecular weight. The loss of water—an OH from one amino acid and a H from the other—leads to the formation of peptide bonds, which in turn connect two or more amino acid molecules, creating increasingly complex structures.

Peptides in Biological Systems

Peptides are short sequences of amino acids (usually ranging from 2 to 50) connected by peptide bonds. Peptides are typically hormones, neurotransmitters, ion channel ligands, and growth factors. They can be encoded, but are frequently produced from bigger precursors by the activity of enzymes such signal peptidases, endopeptidases, and carboxypeptidases. Their stability and bioactivity in cells are affected by post-translational changes such as amidation, acetylation, phosphorylation, sulfation, and glycosylation, which occur after their synthesis. Dissecting biological sources such tissue samples, extracting and isolating the peptides, and then conducting a battery of biochemical and functional tests were the old methods for peptide identification. The development of pancreatic polypeptide hormone (PYY) and glucagon-like peptide (GLP)-1 are prime examples of this. The L cells of the small intestine synthesize GLP-1, a peptide hormone with 30 amino acids, from the proglucagon precursor protein. Insulin and blood glucose levels are both controlled by GLP-1. Recombinant DNA technology made it possible to find GLP-1 in the early 1970s. Sequencing recombinant cDNA from messenger RNAs of several animals, including humans, hamsters, rats, bovines, and anglerfish, allowed scientists to derive the proglucagon gene. The proglucagon cDNA was transfected into cells to shed light on the structure, and then the peptides generated from this gene were determined using chromatography and radioimmunoassays. The bigger proglucagon gene is present in multiple organs, but the GLP-1 and GLP-2 peptides are processed differently depending on the tissue. In the pancreas, they are found as a single large peptide, but in the small intestine, they exist as separate smaller molecules. Pancreatic polypeptide (PP) and PYY are both members of the physiologically active peptide family known as neuropeptide Y. PYY's peculiar COOH-terminal tyrosine amide structure led to its initial detection in pig intestine extracts. Using trypsin or thermolysin to breakdown the materials, COOH-terminal amide determination was used for measurement.

Natural Functions of Peptides

(1) Hormones (e.g., insulin, glucagon)

Peptide hormones are small, water-soluble compounds that include peptide linkages and can have a length and structure ranging from three to two hundred amino acids. Physiological processes like growth and differentiation are impacted by peptide hormones, which are produced locally and have the ability to travel to distant regions. These peptide hormones promote development, maintenance, and function in the tissues they operate upon via paracrine and, maybe, autocrine mechanisms. The size, structure, and function of these hormones vary greatly. Although this short list does not include every endogenous and physiological peptide hormone in the body, it does highlight certain noteworthy peptide families. The hormone insulin is a peptide of 51 amino acids and two chains of disulfide bonds. Another class of peptide hormones, the IGF-1 (insulin-like growth factor 1) family contains three disulfide links. Glucose uptake from the blood and glycogen storage in the liver are two of insulin's many functions in maintaining metabolic homeostasis. After prohormone convertase 2 cleaves proglucagon, a fully processed bioactive peptide called glucagon is formed. When blood sugar drops too low or when amino acid concentrations rise to a healthy level, pancreatic alpha cells secrete this hormone. Energy expenditure and glucose metabolism are both regulated by glucagon, which allows it to promote homeostatic homeostasis throughout the body. Research into this peptide hormone and the processes by which it works lays the groundwork for future treatments for diabetes and other diseases. Similarly to other peptide hormones, secretin has a 27-amino acid sequence that is attached to both its N- and C-termini. The SCT gene is the source of this peptide, which initially transforms into prosecretin, a prohormone. S cells in the duodenal mucosa release it after activation by stomach acid cleaves it into the active peptide form. As a protective mechanism against acid reflux, it triggers the secretion of bicarbonate by the pancreas and bile ducts.

(2) Neurotransmitters (e.g., substance P, endorphins)

Substance P, cholecystokinin, and somatostatin are only a few examples of the neuropeptides that play an essential role as neurotransmitters in the transmission of signals between neurons and between neurons and their effector cells. The most extensive family of chemical messengers consists of neuropeptides. There are more than a thousand peptides in the mammalian brain, but only a small fraction of those have been proven to be neuropeptides (i.e., chemical transmitters). The other peptides in the brain may or may not have any recognized function, but it's still worth exploring the possibility. There are a number of neuropeptides that have been extensively examined and found to have similarities with both classical and nonclassical neurotransmitters. The latter group is referred to as "nonclassical neuropeptides" and will be discussed further below. A wide variety of classical neuropeptides play an important role in several physiological functions, including as reproduction, digestion, regulation of body weight, anxiety, depression, pain, analgesia, memory, awareness, and the regulation of sleep and wakefulness. Classical neurotransmitters and classical neuropeptides share many characteristics, such as being synthesized in presynaptic neurons, stored in secretory vesicles, released into the extracellular space in response to stimulation, bound to receptors on cell surfaces to achieve physiological effects, and finally degraded to render the signaling molecule inactive. Peptidases in the extracellular environment break down neuropeptides, unlike many other neurotransmitters, rather than recycling them back into the original cell. This means that synthesis of a new molecule is required for each neuropeptide molecule released. For this reason, neuropeptides are no longer considered to be the principal messengers across synapses, but rather to have a modulatory function that influences the signaling of classical neurotransmitters. Axon terminals and the cell body can both release neuropeptides, which is a key distinction between the two types of neurotransmitters. In contrast, classical neurotransmitters are mostly secreted by nerve terminals at the synapse. Both classical neuropeptides and classical neurotransmitters are kept in controlled secretory vesicles; however, classical neuropeptides are only found in big dense-core vesicles and not in small synaptic vesicles. Classical neurotransmitters and neuropeptides are housed together in certain vesicles. According to the theory that neuropeptides serve as modulators and classical neurotransmitters are more involved in the fast chemical transmission between cells, the larger dense-core vesicles are released from cells at a slower rate than the smaller synaptic vesicles.

(3) Antimicrobial peptides (AMPs) and their role in innate immunity

As oligopeptides, the number of amino acids in antimicrobial peptides (AMPs) can range from five to more than a hundred. From viruses to parasites, AMPs target a wide variety of species. Cationic amphipathic peptides, anionic antimicrobial peptides/proteins, cationic AMPs, host defense peptides, and α-helical antimicrobial peptides are some of the names that AMPs have had in the past. AMPs are usually little proteins made up of hundreds of amino acids. They form amphipathic α-helices and have a strong cationic surface, which is essential for their ability to fight against microbes. Several possible pathways mediate this action. To start, the traditional wisdom holds that cationic AMPs have the ability to penetrate microbial cell membranes and cause harm within. Secondly, instead of causing a hole in the membrane, some AMPs could induce anionic lipid clustering, which would be disastrous for the target bacteria's survival. Thirdly, some AMPs that are high in proline can hinder bacterial translation by blocking enzymes in the mitochondria or binding directly to the ribosome's polypeptide tunnel. And lastly, defensins and human cathelicidin LL-37 are two examples of AMPs that have the ability to self-assemble with RNAs and control TLR-mediated inflammation.

Among the many chemicals that make up the antimicrobial peptide group are bacteriocins, streptogramins, teicoplanin, and vancomycin. When other antibiotics have failed to alleviate an illness, doctors may turn to the glycopeptide vancomycin, a medicine that has been considered a "drug of last resort" for quite some time. Nevertheless, further antibiotics such televancin, linezolid, daptomycin, and the lipoglycopeptide teicoplanin were created in response to the rise of VRE. A vancomycin derivative with a deacylaminoethyl moiety, telavancin received FDA approval in 2009. In comparison to vancomycin, its effectiveness against C. diff is higher. For C. diff that has developed resistance to vancomycin, Teicoplanin has been given the green light. When compared to vancomycin and teicoplanin, telavancin has several benefits, such as superior in vivo effectiveness, pharmacokinetics, safety, and action against resistant staphylococci, streptococci, and enterococci; it is also simpler to administer. Daptomycin and ramoplanin are cyclic lipopeptides. Streptomyces roseosporus produces daptomycin, an antibiotic that inhibits the growth of Gram-positive bacteria such as vancomycin-resistant Escherichia coli, methicillin-resistant Staphylococcus aureus, and others. In cases of endocarditis, S. aureus bacteremia, or complex infections of the skin or soft tissues, it is prescribed. It enters cells irreversibly, binds to the membrane of the cell, and blocks the action of the plasma membrane; it does not enter the cytoplasm. The ion concentration gradient is destroyed when it inserts its tail into the membrane, which induces membrane depolarization and outflow of K. That stops the target bacterium from producing ATP and absorbing nutrients. It was believed that daptomycin, which was discovered in the 1970s by Eli Lilly and Company, was poisonous.

(4) Regulatory peptides in metabolism and cell signaling

The active peptides, which range in length from 2 to 30 amino acid residues, possess desirable qualities like potent curative effects, minimal side effects, low molecular weights, and ease of absorption. These properties enable them to target tumor tissues with pinpoint accuracy, where they can interact with signal transduction molecules related to tumor growth and metastasis to halt tumor growth and metastasis while promoting cell death in tumor cells. Tumor metabolism signaling pathways that can be targeted with bioactive peptides include PI3K/AKT/mTOR, AMPK, STAT3, TRAIL death receptor, and NF-кB.

A novel kind of polypeptide, encoded by lncRNA LING00961 and present in the nucleus and lysosome, acts as an inhibitor of mTORC1 activity through interactions with the lysosomal V types of ATP enzymes. Spanish for "small regulatory polypeptide of amino acid response," this is the name given to this polypeptide. Additional research has demonstrated that damaged skeletal muscle inhibits the lncRNA encoding SPAR, which decreases mTORC1 activity and helps with anathrepsis. This suggests that mTORC1 activity can be altered in a tissue-specific manner in response to damage, and it adds to the growing body of evidence that lncRNA-coded polypeptides regulate specific organized biological functions. A polypeptide fragment encoding tumstatin, with a relative molecular weight of 28 kDa and 244 amino acid residues, has been found by Li and colleagues within the noncollagen NC1 domain of the collagen ⅎα3 chain. The polypeptide fragment can inhibit the phosphorylation of tyrosine residues in FAK (focal adhesion kinase) when it is combined with integrin αvβ on endotheliocyte surfaces independent of RGD. This inhibits FAK's activity, which in turn suppresses PI3 kinase. Consequently, the activity of PKB/Akt (protein kinase B) would be inhibited and endotheliocyte proliferation would be slowed. Tumstatin, on the other hand, is an essential protein for cellular signal transduction and an inhibitor of mTOR kinases. As a result, it would strengthen the binding of 4E-BP1 to eIF4E and inhibit HAT-dependent translation, leading to the generation of endotheliocytes and, ultimately, their apoptosis.

Advantages of Peptides in Biological Roles

(1) Wound repair

In addition to exogenous peptides, endogenous peptides aid wound healing by stimulating the differentiation of mesenchymal cells, which in turn promotes bacteriolysis within the wound. Syndecan is an antimicrobial peptide derived from wound fluid that is generated by heparan sulfate, a proteoglycan found on the surface of cells. Damaged tissues can heal more quickly when synthdecan activates heparin-binding growth factors and chemicals in the tissue matrix.

(2) Chronic Inflammatory Skin Conditions

A protective barrier against surface assault, particularly by gram-positive and gram-negative bacteria, viruses, and fungi, can be secreted by healthy skin in the form of AMPs. Evidence suggests that peptides contribute to an epithelial microbiome that is continuously disturbed, making the tissue more vulnerable to pathogenic infections and inflammatory skin diseases that last longer than expected. The anti-microbial effect is suppressed in the inflamed skin of atopic dermatitis patients compared to normal participants because typical epidermal AMPs such LL-37, β-defensin-2, and β-defensin-3 are not expressed as much.

(3) Molecular Imaging and Tumor Targeting

Designing peptides that bind to overexpressed receptors, like those involved in cancer progression, or peptides that serve as imaging probes are the primary applications of the mechanism of endogenous peptide and specific receptor binding. In order to detect tumors, these probes might be purposefully created in a lab to imitate endogenous peptides that serve as biomarkers. Therapeutic applications and precise tumor growth detection are both touched by the ramifications of this cutting-edge technology. Modern scientific knowledge, molecular peptide chemistry, and improved targeting strategies offer the promise of these synthetic peptides as a highly specific imaging agent for a variety of diseases using PET/SPECT, optical imaging, and magnetic resonance imaging (MRI).

(4) Immunomodulatory Activity

A well-functioning immune system in humans relies on immunomodulatory activity. Bioactive peptides modulate immune responses through regulating cytokines, producing antibodies, stimulating the immune system with reactive oxygen species, altering tubulin conformation, and blocking protein synthesis. Immunomodulatory effect is also related to peptide structure, hydrophobicity, charge, length, and sequence of amino acids. Specifically, research has shown that hydrolysates of soy proteins, which contain several positively charged peptides and have a low molecular weight, might enhance immunomodulation. Leu-Asp-Ala-Val-Asn-Arg and Met-Met-Leu-Asp-Phe are two examples of the many bioactive peptides produced by plants that have an immunomodulatory effect; they are hydrophobic and have low molecular weights (686 and 655 Da, respectively). Bioactive peptides found in abundance in marine products have found application in the treatment of numerous diseases.

Peptide modifications services at Creative Peptides

Peptides in Medicine

Common roles for therapeutic peptides include those of hormones, growth factors, neurotransmitters, ligands for ion channels, and anti-infective drugs. Along the same lines as biologics, such as therapeutic proteins and antibodies, they bind to receptors on the surface of cells and set off effects within cells. Nevertheless, therapeutic peptides exhibit reduced immunogenicity and possess cheaper production costs in contrast to biologics.

(1) Therapeutic Applications

Peptide drug development has its roots in the utilization of naturally occurring hormones and peptides with established physiological roles to treat disorders brought on by insufficiencies in these hormones, such as type 1 and type 2 diabetes, which are characterized by an inadequate production of insulin. Insulin injections or medications that stimulate insulin secretion-related targets, like the GLP-1 receptor, are the mainstays of diabetes treatment. The first approaches to developing peptide drugs involved looking for hormones and peptides found in nature or finding animal homologues of these substances. Examples of these include insulin, GLP-1, somatostatin, GnRH, 8-Arg-Vasopressin, and oxytocin. In spite of this, a number of natural hormone-mimetic peptide medications were developed as concerns about the limitations of these peptides prompted researchers to focus on improving their natural sequences. medication peptides generated from GLP-1: The 37-amino acid peptide GLP-1 controls insulin secretion and synthesis; it has an extremely short half-life in living organisms. Trulicity (dulaglutide), Victoza (liraglutide), and Ozempic (semaglutide) are the three most popular peptide drugs used to treat type 2 diabetes. Significant efforts were made to alter its sequence in order to make the hormone more stable without compromising its effectiveness or pharmacological effects.

(2) Diagnostics

The diagnostic assay's specificity is proportional to the biomolecular probes' purity. Due to their chemical modifiability and high purity profile, synthetic peptides have found increasing usage in diagnostics in recent decades as a means to obtain precise and reliable information about diseases. Imaging diagnostics and non-imaging diagnostics both make use of the identified peptide probes. In non-imaging diagnostics, biofluids are directly analyzed using methods like microarray or LC-MS/MS, lateral flow devices (also known as point-of-care testing), or Enzyme-Linked Immunosorbent Assay (ELISA). One of the most popular technological platforms is peptide-based ELISA. Additionally, peptides have the potential to serve as imaging technique probes in SPECT and PET scans.

An enzyme-linked immunosorbent assay (ELISA) for the detection of GLP-1 metabolites, including GLP-1 (7-36NH2) and GLP-1 (9-36NH2), was created by Wewer Albrechtsen et al. in 2017. Dipeptidyl peptidase 4 (DPP-4) enzyme quickly transforms the active form of GLP-1, (7-36NH2), into an inactive form or the principal metabolite, (9-36NH2), before it reaches its target through the circulation, a process that involves a 90% conversion. The newly-created ELISA was able to detect both GLP-1 (9-36) NH2 and GLP-1 without any amino groups attached (9-37). An ELISA-based study on the effects of beta1-AAB on "myocardial recovery in patients with systolic heart failure" was published in the journal "ESDEARRCYNDPK," which stands for ADRB1-AB-immunogen-peptide. An elevated C-peptide level is a key diagnostic marker for diabetes. To quickly identify C-peptide in human urine from diabetic patients, Lv et al. created an antibody sandwich ELISA. Using PLL-C-peptide and BSA-C-peptide, respectively, antibodies were produced in hens and rabbits.

(3) Drug Delivery

Some peptides can enter the cell without damaging the integrity of the cellular mem-brane and are considered effective and safe DDSs. This class of peptides is usually classified as cell penetrating peptides (CPPs). CPPs are firstly derived from the α-helical domain of the TAT protein, encoded by the human immunodeficiency virus type 1 (HIV1), and cover residues from 48 to 60. CPPs are short peptides (less than 30 amino acids), mostly cationic and are able to conjugate therapeutic molecules. Nowadays, CPPs contain more than 1800 different sequences that are validated experimentally. There are two main pathways of cellular uptake for CPPs to penetrate the cell: endocytosis and direct translocation. However, some CPPs can enter the cell through either one of two path-ways. For example, recently published studies demonstrated that a bovine lactoferricin L6 CPP can be internalized by endocytosis, however the addition of polyhistidine peptides to this complex can also allow internalization by a direct membrane trans-location. The inability of medications to enter cells is a major challenge in drug delivery. Thanks to cell-penetrating peptides like HIV1-TAT, however, this constraint is no longer an issue. In addition, novel DDS have been developed that exploit TAT's distinct cell-penetrating ability to great effect. Leukemic cells in lymphoblastic leukemia depend heavily on asparagine, which can be effectively combated by a TAT-asparaginase complex that was developed by Kwon and colleagues. Previous research found that TAT domains had the same capacity to translocate many drugs across the membranes of many cell types, and their experiments proved that the TAT-asparaginase complex could penetrate both the hepatocyte cell line (HeLa) and the MOLT-4 tumor cell line with impressive efficiency.

Peptides in Biotechnology and Research

(1) Synthetic Peptides

Due to their more precisely specified amino acid sequences, synthetic peptides have seen more research and are more widely used than their natural counterparts. Current research efforts center on developing methods for delivering drugs in peptide form. Multiple papers have provided concise summaries of these systems, detailing their medical uses, self-assembly architectures, and classifications. Different forms of peptides, including α-helical and β-sheet peptides, as well as cyclic and linear peptides, have the ability to self-assemble into a variety of nanostructures, including nanofibers, nanotubes, nanospheres, and nanocapsules. Important elements influencing the self-assembly of these peptides include temperature, ionic strength, and pH, which are building conditions. The molecular self-assembly of peptides holds great promise for a variety of uses, including nanobiomaterials, cosmetics, medication administration and release, and scaffold materials for tissue engineering. This is because of its exceptional biocompatibility, distinctive self-assembly nanostructures, powerful self-assembly driving force, and unique self-assembly functionalities. Good biocompatibility was established in vitro within 2 days by the hydrogels based on the short homodipeptide phenylalanine-phenylalanine. They were also well-suited for the delivery of two complementary anticancer medicines due to their delayed drug release and excellent stability. As an added bonus, self-assembled micelles were created using lipopeptides crosslinked by disulfide bonds and nanoprecipitation techniques. Hydrophobic interactions were then used to encapsulate doxorubicin (DOX) and RNA into micelles.

(2) Tools for Research

Peptides that emulate the receptors serve as valuable instruments for investigating the intricacies of viral infection mechanisms and for formulating novel therapeutics against HIV-1. In 1998, Drakopoulou's team engineered a peptidic CD4 mimic, termed CD4M, through the examination of site-directed mutagenesis studies, antibody-blocking assays, and the structural analysis of the extracellular fragment of CD4, which pinpointed the CDR H2-like loop of CD4 as the binding site for HIV-1's gp120. To preserve the native conformation of the CDR H2-like loop, the peptide was incorporated into a scorpion toxin, which acted as a structural scaffold. Optimizing CD4M resulted in a variation exhibiting a 100-fold enhancement in affinity for gp120, along with infection-inhibitory properties. Utilizing the X-ray structure of CD4 in conjunction with gp120, Martin's team enhanced the CD4 mimic, culminating in a 27-mer peptide that replicates the CD4 binding site for gp120. This peptide effectively bound to gp120 at low nanomolar concentrations, inhibited CD4 binding to gp120, and induced conformational changes in gp120 akin to those elicited by CD4, from which it was generated. The significance of conformational stability in CD4 mimetic peptides may be further validated by Meier's team. Peptides exhibiting the CD4 binding site for gp120 were covalently stabilized in their loop conformation via cyclization through a disulfide bond between the N- and C-termini. The significance of the critical amino acid phenylalanine 43 was validated at the peptide level through the use of alanine and d-phenylalanine substitution analogs. The results were additionally corroborated by molecular dynamics simulations.

A diagnostic immunoassay can be made more specific by using synthetic peptides that match to a single epitope, just as monoclonal antibodies are more specific than polyclonal antiserum. One major benefit of peptide-based immunoassays is that they may differentiate between infections caused by closely similar virus strains or subtypes. The majority of viral antibodies are detected using synthetic peptides as probes. But they can also be used to make antipeptide antibodies that can find viral antigens in things like cell cultures, saliva, urine, stool, nasopharyngeal swabs, and aspirates. Animals can be immunized with peptides that are at least 15 residues long when they are given as free peptides. Another option is to give them as branching peptides on a core of lysine residues, as peptide-liposome conjugates, or as conjugates with carriers. By choosing peptides that match serotype-specific epitopes, a diagnostic test can be rendered unique to particular viral strains or serotypes. Another option is to employ a single diagnostic probe to detect many viruses when the peptides match conserved epitopes across distinct genera or species of viruses. A synthetic peptide that matches the 37-53th position of the poliovirus VP1 protein, for example, was discovered to detect antibodies against a wide variety of other enteroviruses. Additionally, polio-echo- and coxsackieviruses could be detected in cell cultures by antibodies that were produced against this conserved region of VP1.

Peptides in Agriculture and Food Industry

(1) Biopesticides

In green agriculture, peptides are useful for pest control since they are both effective and environmentally safe. They have a long history of use as pesticides, herbicides, growth regulators for plants, immune inducers for plants, and antibacterial agents. There are a lot of immune induction peptides in the works. Arabidopsis immunological responses and resistance to pathogens are improved by PIP1 and PIP2. In order to make plants more resistant to Pytophthora, Nicotiana tabacum NbPPI1 boosts the immune response. An immunological signal peptide called Zip1 in maize decreases the pathogenicity of the smut fungus. Herbivore defense mechanisms in cowpeas and kidney beans include inceptin, which increases salicylic acid and jasmonic acid, two plant hormones implicated in defense. An indirect line of protection against Spodoptera frugiperda, Inceptin causes plants to release volatile organic compounds like indole and methyl salicylate, which entice the pests' natural enemies. In the defense responses of different plant families, thirty new putative CAPE1-like peptides have been found: Vitinaceae, Solanaceae, Fabaceae, Brassicaceae, and N. tabacum. In parsley, the immune response is set off by Pep-13, which is produced by Phytophthora sojae. Amino acid substitution, cyclization schemes, mimic design, etc. are just a few of the structural optimization methods that have been developed to address the challenges of natural peptides' poor stability and activity. Genetic engineering allows for the modification of naturally occurring peptides to produce new peptides with tailored characteristics. As an illustration, the bioinsecticide Spear® was created by incorporating a glycine-serine dipeptide into ϋ/κ-HXTX-Hv1a, a naturally occurring spider venom peptide, through the use of genetic engineering. As a green tool for pest control in agriculture and public health, this product is regarded as sustainable and effective due to its higher activity, lower risk, and greater persistence compared to the natural product.

(2) Functional Food Ingredients

There is great potential for the development of functional foods and nutraceuticals through the synthesis of bioactive peptides (BPs) from dietary proteins. Antioxidative, antibacterial, immunomodulatory, hypocholesterolaemic, antidiabetic, and antihypertensive are just a few of the many vital functions that BPs play in living organisms. Food additives containing BPs have been utilized to maintain food quality and microbiological safety. Furthermore, peptides have the potential to be used as functional components in the management or avoidance of long-term conditions linked to one's way of life. Nutritional peptides have demonstrated antioxidant capabilities without side effects. A hundred The peptide Pro-Ala-Gly-Tyr, which was extracted from the skin gelatin of Amur sturgeons, had scavenging capabilities against DPPH, ABTS, and hydroxyl radicals, as reported by Nikoo's group. Yesiltas' group looked explored the antioxidant capabilities of peptides made from proteins found in potatoes, seaweed, microbes, and spinach. The most effective peptides were found to be between 6 and 14 amino acids, indicating that shorter peptides exhibited superior antioxidant activity. The effectiveness of preventing oxidation was higher for more negatively charged peptides (down to -6 or up to 2.1) at pH 7 compared to more positively charged peptides (between -0.9 and 0.1). A large number of aromatic and charged residues, including Tyr, Asp, and Lys, were found in the most active peptides, in accordance with previous studies that emphasized the importance of AA composition. While the antioxidant activity was unaffected in the ABTS and liposome tests, Zhang's group showed that casein phosphopeptide (CPP) under Maillard reaction conditions had much reduced bioactivity in the Fenton reaction-deoxyribose tests when galactomannan or xyloglucan were added. The 10 sets of oligopeptides proposed by Durrani's group were derived from Torreya grandis nut. We found that the digested peptide GYCVSDNN from defensin 4 had antioxidant action. Possible mechanisms for the significant hypocholesterolaemic effect of soybean peptides (LPYP, IAVPGEVA, and IAVPTGVA) include enhancing LDL absorption, inhibiting HMG-CoA reductase activity in HepG2 cells, and activation of the LDLR-SREBP-2 signaling pathway. Peptides were generated during the hydrolysis of milk casein using neutrase. Jiang's group looked into how these peptides reduced cholesterol levels. The researchers discovered that the peptides VLPVPQ, VAPFPE, LQPE, and TDVEN reduced the solubility of micellar cholesterol.

Peptides in Cosmetics

While precise limits can vary, peptides are often constituted of up to fifty amino acids and are smaller than proteins. Peptides are among the most well-known bioactive compounds because of their many desirable properties, including their low production costs, low toxicity, and their ability to regulate and signal processes related to homeostasis, stress, immunity, defense, growth, and reproduction. The wide range of physiological effects exhibited by these peptides—which originate from plants, animals, and microbes—has been validated by numerous pieces of evidence from in vitro and in vivo studies, as well as clinical trial results. These effects include antioxidant, anti-aging, moisturizing, collagen-stimulating, and wound-healing capabilities. One of the earliest synthesized bioactive peptides utilized to promote collagen production for anti-aging and wound healing purposes was palmitoyl pentapeptide-3. To aid in skin healing, collagen production, and DNA damage repair, the copper Gly-His-Lys (Cu-GHK) was created and is now used in cosmetic goods. Additional marketed peptides with anti-wrinkle and hydrating capabilities include acetyl hexapeptide-3.

Peptides in Material Science

(1) Nanotechnology

The biomaterials class includes peptide-based materials, which can have a wide variety of forms and functions. The self-assembly of very stable nanomaterials based on peptides was formerly the norm. There are numerous benefits to using peptide-based self-assembly nanomaterials to build well-ordered superstructures as opposed to individual peptides. These include improved thermo- and mechanical stability, semiconductivity, piezoelectricity, and optical characteristics. An α-helix structure was achieved by stabilizing a 17-peptide segment prepared by Mihara et al. with two sets of E-K salt bridges. The segment then self-assembled into stable nanostructures. The chemical production and modification of short α-helical peptides are easy, but their stability in solution is lacking. De novo designing peptide assemblies using ultrashort α-helical peptides is thus still difficult. Modern research by Gazit et al. shown that α-helical heptad peptides can assemble into functional super-helical structures. This heptad peptide's helical shape was stabilized by adding a non-coded α-aminoisobutyric acid into the sequence. By anchoring two phenylalanines at the first and fourth positions of the peptides, they were able to drive the directional self-assembly. The dimeric interface of the conformers is dominated by the intermolecular aromatic interactions given by the side chains of the compounds. A kind of ultrashort helical peptide building blocks for peptide assembly, restricted peptides with crosslinkers are more interesting than linear short helical peptides because of their low molecular free energy and hyperstability.

(2) Biodegradable Materials

A type of chimeric molecule known as a peptide amphiphile (PA) combines a hydrophobic tail with a charged, hydrophilic peptide domain. Although several hydrophobic tails have been investigated, the majority of them contain fatty acid residues. Domains of charged amino acids stabilize the structure that has formed in water through self-assembly triggered by the hydrophobic domain. Furthermore, orderly β-sheet structures can be generated by specific amino acid sequences, leading to fibrillar nanostructures with high aspect ratios. Stupp and colleagues were trailblazers in developing and using this class of materials for a range of medical uses. Neuronal tissue regeneration, drug delivery, antimicrobial systems, peptide vaccines, immune-therapeutic applications, and non-viral gene transfer are just a few of the many recent developments in the wide range of peptide sequences used in PAs. One example is the enhancement of antimicrobial and antiviral peptides by the addition of a fatty acid residue. Recent studies have demonstrated that some cell lines may internalize PAs by lipid-raft mediated endocytosis, and this process does not compromise cell survival.

References

1. Reghupaty S C., et al., Hallmarks of the metabolic secretome, Trends in Endocrinology & Metabolism, 2024, 35(1): 49-61.
2. Martens E., et al., An overview of the industrial aspects of antibiotic discovery, Microbial resources, 2017: 149-168.
3. Bahar A A., et al., Antimicrobial peptides, Pharmaceuticals, 2013, 6(12): 1543-1575.
4. Hafez E S E., et al., Hormones, growth factors, and reproduction, Reproduction in farm animals, 2000: 31-54.
5. Devi L A., et al., Transmitters and peptides: basic principles[M]//Neuroscience in the 21st Century: From Basic to Clinical. Cham: Springer International Publishing, 2022: 2059-2075.
6. Cui H., et al., Advances in the regulatory effects of bioactive peptides on metabolic signaling pathways in tumor cells, Journal of Cancer, 2019, 10(11): 2425.
7. Zaky A A., et al., Bioactivities, applications, safety, and health benefits of bioactive peptides from food and by-products: A review, Frontiers in Nutrition, 2022, 8: 815640.
8. Wang L., et al., Therapeutic peptides: current applications and future directions, Signal transduction and targeted therapy, 2022, 7(1): 48.
9. Pandey S., et al., Role of peptides in diagnostics, International Journal of Molecular Sciences, 2021, 22(16): 8828.
10. Berillo D., et al., Peptide-based drug delivery systems, Medicina, 2021, 57(11): 1209.
11. Regenmortel M H V V. Chapter 6.-The use of peptides for diagnosling viral infections, Laboratory Techniques in Biochemistry and Molecular Biology-Hardbound Edition, 1999, 28: 237-246.
12. Groß A., et al., Synthetic peptides as protein mimics, Frontiers in bioengineering and biotechnology, 2016, 3: 211.
13. Zhang Y M., et al., Peptides, new tools for plant protection in eco-agriculture, Advanced Agrochem, 2023, 2(1): 58-78.
14. Najafian L. A review of bioactive peptides as functional food ingredients: mechanisms of action and their applications in active packaging and food quality improvement, Food & Function, 2023, 14(13): 5835-5857.
15. Ngoc L T N., et al., Insights into bioactive peptides in cosmetics, Cosmetics, 2023, 10(4): 111.
16. Li T., et al., Peptide-based nanomaterials: Self-assembly, properties and applications, Bioactive materials, 2022, 11: 268-282.
17. Kaygisiz K., et al., Peptide amphiphiles as biodegradable adjuvants for efficient retroviral gene delivery, Advanced Healthcare Materials, 2024, 13(4): 2301364.